First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).
Ridolfi L, Gurrieri L, Riva N, Bulgarelli J, De Rosa F, Guidoboni M, Fausti V, Ranallo N, Calpona S, Tazzari M, Petrini M, Granato AM, Pancisi E, Foca F, Dall'Agata M, Bondi I, Amadori E, Cortesi P, Zani C, Ancarani V, Gamboni A, Polselli A, Pasini G, Bartolini D, Maimone G, Arpa D, Tosatto L.
Ridolfi L, et al. Among authors: amadori e.
Front Immunol. 2024 Aug 13;15:1404861. doi: 10.3389/fimmu.2024.1404861. eCollection 2024.
Front Immunol. 2024.
PMID: 39192978
Free PMC article.
Clinical Trial.